During the past decade, Hackensack Meridian Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hackensack Meridian Health" are "COVID-19" (1 trials) and "Homozygous Familial Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Hackensack Meridian Health" in a lesser frequency.

Most popular intervention types in "Hackensack Meridian Health" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lomitapide" (1 trials), "Omega-3 (EPA+DHA)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hackensack Meridian Health" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hackensack Meridian Health". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hackensack Meridian Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hackensack Meridian Health, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".